Literature DB >> 32330213

Boosting two-photon photodynamic therapy with mitochondria-targeting ruthenium-glucose conjugates.

Jiangping Liu1, Xinxing Liao, Kai Xiong, Shi Kuang, Chengzhi Jin, Liangnian Ji, Hui Chao.   

Abstract

Herein, we present a series of dual-targeted ruthenium-glucose conjugates that can function as two-photon absorption (TPA) PDT agents to effectively destroy tumors by preferentially targeting both tumor cells and mitochondria. The in vivo experiments revealed an excellent tumor inhibitory efficiency of the dual-targeted TPA PSs.

Entities:  

Year:  2020        PMID: 32330213     DOI: 10.1039/d0cc01148g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Cell membranes targeted unimolecular prodrug for programmatic photodynamic-chemo therapy.

Authors:  Jie Yuan; Rong Peng; Dongdong Su; Xingxing Zhang; Hepeng Zhao; Xiujuan Zhuang; Mei Chen; Xiaobing Zhang; Lin Yuan
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

2.  Internal light source for deep photodynamic therapy.

Authors:  Buhong Li; Li Lin
Journal:  Light Sci Appl       Date:  2022-04-06       Impact factor: 17.782

3.  Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds.

Authors:  Xia Hu; Ning-Yi Liu; Yuan-Qing Deng; Shan Wang; Ting Liu; Xue-Wen Liu
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.